Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBriefing
FDA approved pirtobrutinib for untreated CLL/SLL without 17p deletion. The commercial question now shifts to s…
The WeekDrug Channels ↗
Informa's PBM Contracting Summit December 8-9, 2026 | Chicago, IL Drug Channels readers save 10% with code 26D…
The WeekSTAT News ↗
Karl Deisseroth, Peter Hegemann, and Georg Nagel are the joint recipients of the 2026 Nobel Prize in Physiolog…
The WeekPharmaceutical Technology ↗
The US FDA has approved an expanded indication for Lilly's Jaypirca as a first-line treatment for adults with …
The WeekFDA (Drugs) ↗
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have …
The WeekBioPharma Dive ↗
Why diagnostic-driven therapies need a new commercialization model to reach more eligible patients.…
The WeekAJMC ↗
Simulating the Impact of the Transforming Episode Accountability Model…
The WeekBriefing
The U.S. approved 10 drugmakers for a 340B pilot that lets them offer rebates instead of upfront discounts to …
The WeekAJMC ↗
Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment…
The WeekBriefing
A quiet but telling set of moves this week: a big pharma exit after weak cancer-drug testing, a biosimilar par…
The WeekAJMC ↗
Dual-Eligible Enrollees Favor Switching MA Plans Over Leaving MA…
The WeekSTAT News ↗
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring use…
The WeekSTAT News ↗
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA ca…
The WeekBioPharma Dive ↗
The latest installment in BioPharma Dive's data visualization series features a closer look at Kodiak's stock …
The WeekBioPharma Dive ↗
In exchange for a $575 million payment up front, Abogen Biosciences will furnish Novartis with access to its R…
The WeekPharmaVoice ↗
Roche announced it's building autonomous AI-powered labs; how a clinical hold on an epilepsy trial could impac…
The WeekPharmaceutical Technology ↗
Summit is currently developing Ivonescimab in combination with other drugs across several types of solid tumou…
The WeekPharmaVoice ↗
Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory disease…
The WeekKFF Health News ↗
This brief analyzes the Medicare Part D stand-alone prescription drug plan (PDP) market for 2027. The analysis…
The WeekBriefing
KFF’s Medicare overview is basic by design, but the numbers are the point. A program covering 68 million peopl…
The WeekDrug Channels ↗
Today's guest post comes from Kristen Magee, Vice President of Methodology & Enablement at AssistRx. Kristen e…
The WeekPharmaceutical Technology ↗
Unlike other therapies in this class, Abogen's ABO2203 is designed to produce a T-cell engager protein in vivo…
The WeekPharmaceutical Technology ↗
In this issue: Key themes of CPHI 2026, the GLP-1 manufacturing shift, cold chain logistics, and more.…
The WeekSTAT News ↗
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress t…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.